Company works to adapt human therapies for animals

02/5/2013 | Boston Herald

Aratana, a company that licenses and tailors compounds from human drugs for animal health conditions, expects to bring its therapies to the U.S. and European markets in 2016. The company is developing a pain medication for pets with osteoarthritis, an appetite stimulant and a pet formulation of Novocain, according to physician and CEO Steven St. Peter.

View Full Article in:

Boston Herald

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Director, Corporate Counsel
Tarrytown, NY